Summary
This prediction ended on 14.12.22 with a price of €0.39. Massive losses of -62.95% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Balyo | 0.375% | 0.375% | 110.609% | 35.868% |
| iShares Core DAX® | 0.650% | 3.212% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 1.650% | 0.322% | 5.422% | 113.046% |
| iShares Nikkei 225® | 1.232% | 1.549% | 15.333% | 47.267% |
| iShares S&P 500 | 1.413% | 0.282% | 3.125% | 68.687% |
Comments by krebskrebs for this prediction
In the thread Balyo diskutieren
Buy mit Kursziel 1,4
In the thread Trading Balyo
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

